Russell Investments Group, Ltd. Cyma Bay Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$12.63 - $24.47 $1.36 Million - $2.63 Million	107,451 Added 2621.4%	111,550 $2.63 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $44,515 - $72,224	4,099 New	4,099 $61,000
Q1 2021 May 10, 2021	SELL	$4.23 - $6.55 $170,545 - $264,082	-40,318 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$5.73 - $9.03 $189,158 - $298,098	33,012 Added 451.85%	40,318 $230,000
Q2 2020 Aug 05, 2020	SELL	$1.41 - $4.25 $24,948 - $75,199	-17,694 Reduced 70.78%	7,306 $25,000
Q4 2019 Jan 29, 2020	BUY	$1.33 - $5.93 $33,250 - $148,250	25,000 New	25,000 $49,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.